Biomerica, Inc. BMRA
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -61,700.00% | 25.84% | -12.81% | -38.95% | 100.15% |
| Total Depreciation and Amortization | -22.55% | 6.73% | 6.06% | 3.00% | 5.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.52% | -256.33% | -44.44% | -29.05% | 89.36% |
| Change in Net Operating Assets | 143.27% | -40.48% | -56.60% | 235.96% | -151.14% |
| Cash from Operations | -199.25% | -37.76% | -19.62% | -25.28% | 80.06% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -375.00% | -- | -- |
| Cash from Investing | -- | -- | -375.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 137.59% | -- | -96.43% | 25.77% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | 93.55% | 8.33% | -- |
| Cash from Financing | 142.50% | 17,520.00% | -96.49% | 26.84% | -- |
| Foreign Exchange rate Adjustments | -300.00% | -162.50% | 200.00% | 75.00% | 133.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.89% | 95.75% | -275.95% | -13.84% | 148.44% |